SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies

Highlights • A 4-antigen S. aureus vaccine (SA4Ag) targeting multiple virulence factors. • A Phase 1 study after finalizing manufacturing process prior to an efficacy study. • SA4Ag was well tolerated with a satisfactory safety profile in adults 18–

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2017-02, Vol.35 (8), p.1132-1139
Hauptverfasser: Begier, Elizabeth, Seiden, David Joshua, Patton, Michael, Zito, Edward, Severs, Joseph, Cooper, David, Eiden, Joseph, Gruber, William C, Jansen, Kathrin U, Anderson, Annaliesa S, Gurtman, Alejandra
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • A 4-antigen S. aureus vaccine (SA4Ag) targeting multiple virulence factors. • A Phase 1 study after finalizing manufacturing process prior to an efficacy study. • SA4Ag was well tolerated with a satisfactory safety profile in adults 18–
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2017.01.024